Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Androgenetic alopecia is not linked to higher risks of hypertension or hyperaldosteronism.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Inflammation, possibly triggered by a specific bacteria and activated by UV radiation, may contribute to male pattern baldness.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Most patients improved with oral contraceptives, but some needed additional treatment.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Hormonal imbalances, especially high androgen levels and insulin resistance, are linked to worse acne in adult women.

Long-term use of hormonal supplements can cause hair loss in women.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

High doses of finasteride cause cell growth and tumors in mice.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Prenatal antiandrogen treatment altered hormone levels in adult spotted hyenas, affecting males and females differently.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

New genes and pathways are important for testosterone production and male sexual development.